First Time Loading...

Mediclin AG
XETRA:MED

Watchlist Manager
Mediclin AG Logo
Mediclin AG
XETRA:MED
Watchlist
Price: 2.92 EUR -1.35% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one MED stock under the Base Case scenario is 15.34 EUR. Compared to the current market price of 2.92 EUR, Mediclin AG is Undervalued by 81%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MED Relative Value
Base Case
15.34 EUR
Undervaluation 81%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
85
vs Industry
89
Median 3Y
0.2
Median 5Y
0.3
Industry
2.4
Forward
0.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
45
Median 3Y
8.1
Median 5Y
12.2
Industry
23.4
Forward
8.4
More Details
1.8
P/OCF
P/OCF
Price to OCF
1.8
vs History
73
vs Industry
53
Median 3Y
2.4
Median 5Y
2.4
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-3.2
Industry
23.2
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
76
vs Industry
72
Median 3Y
0.8
Median 5Y
1
Industry
2.3
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
80
vs Industry
79
Median 3Y
0.6
Median 5Y
0.7
Industry
2.5
Forward
0.5
More Details
0.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.6
vs History
80
vs Industry
84
Median 3Y
0.7
Median 5Y
0.8
Industry
5.3
More Details
3.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.8
vs History
82
vs Industry
49
Median 3Y
4.4
Median 5Y
5.8
Industry
12.6
Forward
4.3
More Details
21
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21
vs History
52
vs Industry
23
Median 3Y
17.8
Median 5Y
22
Industry
17.2
Forward
9.5
More Details
5
EV/OCF
EV/OCF
Enterprise Value to OCF
5
vs History
66
vs Industry
47
Median 3Y
5.6
Median 5Y
5.8
Industry
15.3
More Details
9.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
9.7
vs History
39
vs Industry
35
Median 3Y
9.4
Median 5Y
9.4
Industry
19.8
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
66
vs Industry
75
Median 3Y
0.6
Median 5Y
0.6
Industry
2
More Details

Multiples Across Competitors

MED Competitors Multiples
Mediclin AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Mediclin AG
XETRA:MED
138.7m EUR 0.2 -12.9 3.8 21
US
HCA Healthcare Inc
NYSE:HCA
81.4B USD 1.2 14.9 9.1 12
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
109.1B SAR 11.5 53.3 46.3 53.2
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
119.3B CNY 6.2 35.6 23.6 23.6
ZA
Netcare Ltd
JSE:NTC
15.2B Zac 0 0 0 0
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
14.8B Zac 0 0 0 0
TH
Bangkok Dusit Medical Services PCL
SET:BDMS
460.9B THB 4.6 32.1 18.9 24.7
US
Tenet Healthcare Corp
NYSE:THC
11.7B USD 0.6 4.5 5.8 7.4
BR
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
60.5B BRL 1.3 29.6 9 11.4
MY
IHH Healthcare Bhd
KLSE:IHH
55.4B MYR 2.6 18.8 10.7 14.6
US
Universal Health Services Inc
NYSE:UHS
11.3B USD 0.8 13.8 8.6 12.4

See Also

Summary
MED intrinsic value, competitors valuation, and company profile.
DCF Valuation
MED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MED stock valuation using valuation multiples.
Wall Street Estimates
MED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.